Accordingly, body weight reduction is effective for the treatment of type 2 diabetes with visceral fat accumulation [41], and the reduction of visceral and subcutaneous fat was reported to correlate with the elevation of adiponectin levels [42]. Here, ADIPOQ is linked to type 2 diabetes mellitus.